uMed's AccessCMD next-generation Cardiometabolic Cohort hits 2000 patient milestone in less than 4 months

Contributed by: PR Newswire

Tags

AccessCMD-UMed

More Like This

PR Newswire associated0

AMO Pharma in Collaboration with Population Health Research Institute (PHRI) and Venca Research Inc. Announces FDA Advice on Potential Phase 3 Development Path for AMO-02 in Treatment of Arrhythmogenic Cardiomyopathy (ACM)

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol (Photo: Business Wire)

Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study

Unimed Expands Maritime Healthcare Platform with Growing Adoption of Telemed Plus

PR Newswire associated0

Emmes Introduces Telehealth Capabilities into Advantage eClinical

GlobeNewswire associated0

PMcardio Is The First Certified Solution To Outperform Doctors in Heart Attack Detection With AI

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are

PR Newswire associated0

Global Heart Hub's Insights from Patients living with Elevated Cholesterol reveals the Importance of Shared Decision-Making

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors